Your browser doesn't support javascript.
loading
Structural modifications toward improved lead-203/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumors.
Lee, Dongyoul; Li, Mengshi; Liu, Dijie; Baumhover, Nicholas J; Sagastume, Edwin A; Marks, Brenna M; Rastogi, Prerna; Pigge, F Christopher; Menda, Yusuf; Johnson, Frances L; Schultz, Michael K.
  • Lee D; Department of Physics and Chemistry, Korea Military Academy, Seoul, Republic of Korea.
  • Li M; Perspective Therapeutics, Inc., Coralville, IA, USA.
  • Liu D; Perspective Therapeutics, Inc., Coralville, IA, USA.
  • Baumhover NJ; Perspective Therapeutics, Inc., Coralville, IA, USA.
  • Sagastume EA; Perspective Therapeutics, Inc., Coralville, IA, USA.
  • Marks BM; Perspective Therapeutics, Inc., Coralville, IA, USA.
  • Rastogi P; Department of Pathology, The University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Pigge FC; Department of Chemistry, The University of Iowa, ML B180 FRRBP, 500 Newton Road, Iowa City, IA, 52240, USA.
  • Menda Y; Department of Radiology, The University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Johnson FL; Perspective Therapeutics, Inc., Coralville, IA, USA.
  • Schultz MK; Perspective Therapeutics, Inc., Coralville, IA, USA. michael-schultz@uiowa.edu.
Eur J Nucl Med Mol Imaging ; 51(4): 1147-1162, 2024 Mar.
Article en En | MEDLINE | ID: mdl-37955792

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Octreótido / Tumores Neuroendocrinos Límite: Animals / Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Octreótido / Tumores Neuroendocrinos Límite: Animals / Humans Idioma: En Año: 2024 Tipo del documento: Article